Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Chi Lin

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 14, 2012
CIP2A is a predictor of poor prognosis in colon cancerHao-Wei Teng, Shung-Haur Yang, Jen-Kou Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 5, 2011
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot studyYa-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease|December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal CancerKuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
International Journal of Cancer|April 14, 2019
RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancerWei-Chung Cheng, Tsai-Tsen Liao, Chun-Chi Lin, et al.
Scientific Reports|July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spreadHung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 23, 2024
The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomyJin-Han Yang, Wen-Ling Lin, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver MetastasisTien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Clinical Colorectal Cancer|April 25, 2023
Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic DisabilityChih-Wen Chen, Tao-Shen Ou, Wei-Shone Chen, et al.
Plant Disease|May 18, 2022
Surveillance of Rice Blast Resistance Effectiveness and Emerging Virulent Isolates in TaiwanJauhar Syauqi, Rong-Kuen Chen, An-Hsiu Cheng, et al.
Clinical and Translational Gastroenterology|December 5, 2024
Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in TaiwanHsin-Yun Wu, Meng-Tzu Weng, Jen-Wei Chou, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 14, 2012
CIP2A is a predictor of poor prognosis in colon cancerHao-Wei Teng, Shung-Haur Yang, Jen-Kou Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 5, 2011
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot studyYa-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease|December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal CancerKuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
International Journal of Cancer|April 14, 2019
RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancerWei-Chung Cheng, Tsai-Tsen Liao, Chun-Chi Lin, et al.
Scientific Reports|July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spreadHung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 23, 2024
The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomyJin-Han Yang, Wen-Ling Lin, Wei-Shone Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver MetastasisTien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Clinical Colorectal Cancer|April 25, 2023
Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic DisabilityChih-Wen Chen, Tao-Shen Ou, Wei-Shone Chen, et al.
Plant Disease|May 18, 2022
Surveillance of Rice Blast Resistance Effectiveness and Emerging Virulent Isolates in TaiwanJauhar Syauqi, Rong-Kuen Chen, An-Hsiu Cheng, et al.
Clinical and Translational Gastroenterology|December 5, 2024
Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in TaiwanHsin-Yun Wu, Meng-Tzu Weng, Jen-Wei Chou, et al.
Pageof 16